Quantitative Interpretation of Human Biomonitoring Data

Toxicology and Applied Pharmacology

Volumn 231, Issue 1, 2008, Pages 122-133

  Clewell, Harvey J ^a   Tan, Yu Mei ^a   Campbell, Jerry L ^a   Andersen, Melvin E ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

Author keywords

Biomonitoring; PBPK modeling; Pharmacokinetics; Risk assessment

Indexed keywords

BENZENE; BIOLOGICAL MARKER; CHLOROFORM; CHLORPYRIFOS; DIOXIN; METHYLMERCURY; PERFLUOROOCTANESULFONIC ACID; TERT BUTYL METHYL ETHER; TRICHLOROETHYLENE; TRIHALOMETHANE;

BIOLOGICAL MONITORING; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); DOSIMETRY; DRUG TISSUE LEVEL; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; PHARMACOKINETIC MODELING; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING; QUANTITATIVE ASSAY; REVERSE DOSIMETRY; REVIEW; RISK ASSESSMENT; STATISTICAL MODEL; TOXICITY TESTING;

ANIMALS; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HEALTH; HUMANS; RISK ASSESSMENT;

ANIMALIA;

EID: 48449086575     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.04.021     Document Type: Review

References (75)

1. Adams J.C., Dills R.L., Morgan M.S., Kalman D.A., and Pierce C.H. A physiologically based toxicokinetic model of inhalation exposure to xylenes in Caucasian men. Reg. Toxicol. Pharmacol. 43 (2005) 203-214
2. Allen B.A., Hack C.E., and Clewell H.J. Use of Markov chain Monte Carlo analysis with a physiologically based pharmacokinetic model of methylmercury to estimate exposures in United States women of child-bearing age. Risk Anal. 27 4 (2007) 947-959
3. Amin-Zaki L., Elhassani S., Majeed M., Clarkson T., Doherty R., and Greenwood M. Perinatal methylmercury poisoning in Iraq. Am. J. Dis. Child 130 (1976) 1070-1076
4. Anderson W.A.C., Castle L., Scotter M.J., Massey R.C., and Springall C. A biomarker approach to measuring human dietary exposure to certain phthalate diesters. Food Addit. Contam. 18 12 (2001) 1068-1074
5. Andersen M.E., Clewell H.J., Tan Y.-M., Butenhoff J.L., and Olsen G.W. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - Probing the determinants of long plasma half-lives. Toxicology 227 1-2 (2006) 156-164
6. Aylward L.L., Brunet R.C., Carrier G., Hays S.M., Cushing C.A., Needham L.L., Patterson Jr. D.G., Gerthoux P.M., Brambilla P., and Mocarelli P. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J. Exp. Anal. Environ. Epidemiol. 15 (2005) 51-65
7. Aylward L.L., Brunet R.C., Starr T.B., Carrier G., Delzell E., Cheng H., and Beall C. Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination. Risk Anal. 25 (2005) 945-956
8. Backer L.C., Ashley D.L., Bonin M.A., Cardinali F.L., Kieszak S.M., and Wooten J.V. Household exposures to drinking water disinfection by-products: whole blood trihalomethane levels. J. Expo. Anal. Environ. Epidemiol. 10 (2000) 321-326
9. Barton H.A., and Clewell III H.J. Evaluating Noncancer Effects of Trichloroethylene: Dosimetry, Mode of Action, and Risk Assessment. Environ. Health Perspect. 108 suppl 2 (2000) 323-334
10. Blancato J.N., and Chiu N. Predictive modeling for uptake and tissue distribution from human exposures. In: Craun G.F. (Ed). In Safety of Water Disinfection: Balancing chemical & microbial risks (1993), International Life Sciences Institute, Washington, D.C. 303-316
11. Bouchard M., Carrier G., Brunet R.C., Bonvalot Y., and Gosselin N.H. Determination of biological reference values for chlorpyrifos metabolites in human urine using a toxicokinetic approach. J. Occup. Environ. Hyg. 2 (2005) 155-168
12. Brown R.P., Delp M.D., Lindstedt S.L., Rhomberg L.R., and Beliles R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Indust. Health 13 4 (1997) 407-484
13. Butenhoff J., Gaylor D., Moore J., Olsen G., Rodricks J., Mandel J., and Zobel L. Characterization of risk for general population exposure to perfluorooctanoate. Regul. Toxicol. Pharm. 39 (2004) 363-380
14. Calafat A., Kuklenyik Z., Caudill S., Reidy J., and Needham L. Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ. Sci. Technol. 40 (2006) 2128-2134
15. Centers for Disease Control and Prevention (CDC), 1996. Third National Health and Nutrition Examination Survey (NHANES III, 1988-94) (1996), National Center for Health Statistics, Atlanta, Georgia
16. Centers for Disease Control and Prevention (CDC), 2001. National Report on Human Exposure to Environmental Chemicals. NCEH Pub. No. 01-0164 (2001), National Center for Environmental Health, Atlanta, Georgia
17. Centers for Disease Control and Prevention (CDC), 2003. National Report on Human Exposure to Environmental Chemicals. NCEH Pub. No. 03-0367 (2003), National Center for Environmental Health, Atlanta, Georgia
18. Centers for Disease Control and Prevention (CDC), 2005. Third National Report on Human Exposure to Environmental Chemicals. NCEH Pub. No. 05-0570 (2005), National Center for Environmental Health, Atlanta, Georgia
19. Chinery R.L., and Gleason A.K. A compartmental model for the prediction of breath concentration and absorbed dose of chloroform after exposure while showering. Risk Anal. 13 (1993) 51-62
20. Clewell H.J., and Andersen M.E. Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health 1 (1985) 111-131
21. Clewell R.A., and Gearhart J.M. Pharmacokinetics of toxic chemicals in breast milk: Use of PBPK models to predict infant exposure. Environ. Health Perspect. 110 (2002) A333-A337
22. Clewell R.A., and Clewell H.J. Development and Specification of Physiologically Based Pharmacokinetic Models for Use in Risk Assessment. Reg. Tox. Pharm. 50 (2008) 129-143
23. Clewell H.J., Andersen M.E., and Barton H.A. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environ. Health Perspect. 110 (2002) 85-93
24. Clewell H.J., Crump K.S., Gentry P.R., and Shipp A.M. Site-specific Reference Dose for methylmercury for fish-eating populations. Fuel Processing Technol. 65-66 (2000) 43-54
25. Clewell H.J., Gearhart J.M., Gentry P.R., Covington T.R., VanLandingham C.B., Crump K.S., and Shipp A.M. Evaluation of the uncertainty in an oral Reference Dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19 (1999) 547-558
26. Clewell H.J., Gentry P.R., Covington T.R., and Gearhart J.M. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108 Suppl. 2 (2000) 283-305
27. Clewell H.J., Gentry P.R., Gearhart J.M., Allen B.C., and Andersen M.E. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Sci. Total Environ. 274 1-3 (2001) 37-66
28. Clewell H.J., Gentry P.R., Gearhart J.M., Covington T.R., Banton M.I., and Andersen M.E. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol. Sci. 63 (2001) 160-172
29. Clewell H.J., Gentry P.R., Covington T.R., Sarangapani R., and Teeguarden J.G. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 79 (2004) 381-393
30. Clewell R.A., Kremer J.J., Williams C.C., Campbell J.L., Andersen M.E., and Borghoff S.J. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: Evaluation with a PBPK model. Toxicol. Sci. (2008) Epub ahead of print
31. Constan A.A., Sprankle C.S., Peters J.M., Kedderis G.L., Everitt J.I., Wong B.A., Gonzalez F.L., and Butterworth B.E. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol. Appl. Pharmacol. 160 (1999) 120-126
32. Corley R.A., Gordon S.M., and Wallace L.A. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. Toxicol. Sci. 53 (2000) 13-23
33. Gearhart J.M., Clewell H.J., Crump K.S., Shipp A.M., and Silvers A. Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in a large epidemiological study. Water Air Soil Pollut. 80 (1995) 49-58
34. Georgopoulos P.G., Roy A., and Gallo M.A. Reconstruction of short-term multiroute exposure to volatile organic-compounds using physiologically-based pharmacokinetic models. J. Expo. Anal. Environ. Epidemiol. 4 (1994) 309-328
35. Gosselin N.H., Brunet R.C., Carrier G., and Dosso A. Worker exposures to triclopyr: Risk assessment through measurements in urine samples. Ann. Occup. Hyg. 59 (2005) 415-422
36. Gosselin N.H., Brunet R.C., Carrier G., Bouchard M., and Feeley M. Reconstruction of methylmercury intakes in indigenous populations from biomarker data. J. Expo. Sci. and Environ. Epidemiol. 16 (2006) 19-29
37. Haddad S., Tardif G.-C., and Tardif R. Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: Trichloroethylene and trihalomethanes. J. Toxicol. Environ. Health A 69 (2006) 2095-2136
38. Harada K., Inoue K., Morikawa A., Yoshinaga T., Saito N., and Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res. 99 2 (2005) 253-261
39. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., and Pyatt D.W. Biomonitoring equivalents: A screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 47 (2007) 96-109
40. Hoppin J.A., Brock J.W., Davis B.J., and Baird D.D. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ. Health Perspect. 110 5 (2002) 515-518
41. International Commission on Radiological Protection (ICRP), 2002. Basic anatomical and physiological data for use in radiological protection: Reference values. ICRP Publication 89 (2002)
42. Jo W.K., Weisel C.P., and Lioy P.J. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal. 10 (1990) 575-580
43. Levesque B., Ayotte P., Tardif R., Charest-Tardif G., Dewailly E., Prud'Homme D., Gingras G., Allaire S., and Lavoie R. Evaluation of the health risk associated with exposure to chloroform in indoor swimming pools. J. Toxicol. Environ. Health A 61 (2000) 101-119
44. Levesque B., Ayotte P., Tardif R., Ferron L., Gingras S., Schlouch E., Gingras G., Levallois P., and Dewailly E. Cancer risk associated with household exposure to chloroform. J. Toxicol. Environ. Health A 65 (2002) 489-502
45. Liao K.H., Tan Y.-M., and Clewell H.J. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds (VOCs). Risk Anal. 27 5 (2007) 1223-1236
46. Lorber M. A pharmacokinetic model for estimating exposure of Americans to dioxin-like compounds in the past, present, and future. (2002). A pharmacokinetic model for estimating exposure of Americans to dioxin-like compounds in the past, present, and future. Sci. Total Environ. 288 (2002) 81-95
47. Mayer P.W., DeOreo W.B., Optiz E.M., Kiefer J.C., Davis W.Y., Dziegielewski B., and Nelson J.O. Residential End Uses of Water (1999), AWWA Research Foundation, Denver
48. National Research Council (NRC), 2006. Human Biomonitoring for Environmental Chemicals (2006), The National Academies Press, Washington DC 316
49. Olsen G.W., Hansen K.J., Stevenson L.A., Burris J.M., and Mandel J.H. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ. Sci. Technol. 37 (2003) 888-891
50. Olsen G., Church T.R., Hansen K., Burris J.M., Butenhoff J., Mandel J.H., and Zobel L.R. Quantitative evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J. Children's Health 2 (2004) 53-76
51. Olsen G.W., Church T.R., Larson E.B., van Belle G., Lundberg J.K., Hansen K.J., Burris J.M., Mandel J.H., and Zobel L.R. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 54 (2004) 1599-1611
52. Olsen G., Ehresman D., Froehlich J., Burris J.M., and Butenhoff J. Evaluation of the half-life (T1/2) of elimination of perfluorooctanesulfonate (PFOS), perfluorohexanesulfonate (PFHS), and perfluorooctanonate (PFOA) from human serum (2005). http://www.chem.utoronto.ca/symposium/fluoros/pdfs/TOX017Olsen.pdf http://www.chem.utoronto.ca/symposium/fluoros/pdfs/TOX017Olsen.pdf
53. Pleil J.D., Kim D., Prah J.D., and Rappaport S.M. Exposure reconstruction for reducing uncertainty in risk assessment: example using MTBE biomarkers and a simple pharmacokinetic model. Biomarkers. 12 4 (2007) 331-348
54. Pohl L.R., Martin J.L., and George J.W. Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem. Pharmacol. 29 (1980) 3271-3276
55. Poulin P., and Krishnan K. Molecular structure-based prediction of the toxicokinetics of inhaled vapors in humans. Inter. J. Toxicol. 18 (1999) 7-18
56. Roy A., and Georgopoulos P.G. Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models. J. Exp. Anal. Environ. Epidemiol. 8 (1998) 407-422
57. Roy A., Weisel C.P., Gallo M., and Georgopoulos P. Studies of multiroute exposure/dose reconstruction using physiologically based pharmacokinetic models. J. Clean Technol., Environ. Toxicol. Occup. Med. 5 (1996) 285-295
58. Saghir S.A., Mendrala A.L., Bartels M.J., Day S.J., Hansen S.C., Sushynski J.M., and Bus J.S. Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. Toxicol. Appl. Pharmacol. 211 3 (2006) 245-260
59. Shipp A.M., Gentry P.R., Lawrence G., VanLandingham C., Covington T., Clewell H.J., Gribben K., and Crump K. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol. Indust. Health 16 9-10 (2000) 335-438
60. Silva M.J., Barr D.B., Reidy J.A., Kato K., Malek N.A., Hodge C.C., Hurtz III D., Calafat A.M., Needham L.L., and Brock J.W. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch. Toxicol. 77 10 (2003) 561-567
61. Slikker Jr. W., Andersen M.E., Bogdanffy M.S., Bus J.S., Cohen S.D., Conolly R.B., David R.M., Doerrer N.G., Dorman D.C., Gaylor D.W., Hattis D., Rogers J.M., Setzer R.W., Swenberg J.A., and Wallace K. Dose-dependent transitions in mechanisms of toxicity. Toxicol. Appl. Pharmacol. 201 3 (2004) 203-225
62. Slikker Jr. W., Andersen M.E., Bogdanffy M.S., Bus J.S., Cohen S.D., Conolly R.B., David R.M., Doerrer N.G., Dorman D.C., Gaylor D.W., Hattis D., Rogers J.M., Setzer R.W., Swenberg J.A., and Wallace K. Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol. Appl. Pharmacol. 201 3 (2004) 226-294
63. Sohn M.D., McKone T.E., and Blancato J.N. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study. J. Expo. Anal. Environ. Epidemiol. 14 (2004) 204-213
64. Stern A.H. A revised estimate of the maternal methyl mercury intake dose corresponding to a measured cord blood mercury concentration. Environ. Health Perspect. 113 (2005) 155-163
65. Tan Y.-M., Liao K.H., Conolly R.B., Blount B.C., Mason A.M., and Clewell H.J. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. J. Toxicol. Environ. Health, Part A 69 (2006) 1727-1756
66. Tan Y.-M., Liao K.H., and Clewell H.J. Reverse dosimetry: Interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. J. Exp. Sci. Environ. Epidemiol. 17 (2007) 591-603
67. Thomas R.S., Allen B.C., Nong A., Yang L., Bermudez E., Clewell III H.J., and Andersen M.E. A Method to integrate Benchmark Dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 98 1 (2007) 240-248
68. U.S.EPA, 1996. Descriptive statistics tables from a detailed analysis of the National Human Activity Pattern Survey (NHAPS) data (1996), Office of Research and Development, Washington, D.C.
69. U.S.EPA, 2000. Estimated per capita water ingestion in the United States: Based on data collected by the United States Department of Agriculture's 1994-96 Continuing Survey of Food Intakes by Individuals (2000), Office of Water, Washington, D.C.
70. U.S.EPA, 2001. Stage 1 disinfectants and disinfection byproducts rule: A quick reference guide (2001), Office of Water, Washington, D.C.
71. Wallace L. Human exposure and body burden for chloroform and other trihalomethanes. Crit. Rev. Environ. Sci. Technol. 27 (1997) 113-194
72. Weisel C., Yu R., Roy A., and Georgopoulos P. Biomarkers of environmental benzene exposure. Environ. Health Perspect. 104 Suppl. 6 (1996) 1141-1146
73. Weisel C.P., Little J.C., Chiu N., Pandis S.N., Davidson C., and Wilkes C.R. Developing exposure estimates. In: Olin S.S. (Ed). In Exposure to Contaminants in Drinking Water (1999), International Life Sciences Institute, Washington, DC
74. Wittassek M., Wiesmuller G.A., Koch H.M., Eckard R., Dobler L., Muller J., Angerer J., and Schluter C. Internal phthalate exposure over the last two decades-a retrospective human biomonitoring study. Int. J. Hyg. Environ. Health 210 3-4 (2007) 319-333
75. Yager J.W., Clewell III H.J., Hicks J.B., and Fabianova E. Airborne exposure to arsenic occurring in fly ash. In: Chappel W.R., Abernathy C.O., and Calderon R.L. (Eds). Arsenic Exposure and Health Effects (1999), Elsevier Science, Oxford, United Kingdom